ILLUCCIX
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for ILLUCCIX, covering 2021-12-17 to 2026-01-12. Get the full timeline:
Most recent: Clinical Trial Update: Non-significant Risk (NSR) Study of [68Ga]-PSMA-11 (Illuccix) as a BgRT BioGuide on RefleXion X1